KARD
Kardigan, Inc. • NASDAQ
$21.99 ▼ -1.21% (-0.27)
KARD
Kardigan, Inc.NASDAQ • $21.99 ▼ -1.21% (-0.27)
Market Cap $2.04 B
52w High $27.00
52w Low $16.25
P/E -10.04
Volume 214.15K
Outstanding Shares 89.34M
Market Cap $2.04 B
52w High $27.00
52w Low $16.25
P/E -10.04
Volume 214.15K
Outstanding Shares 89.34M
About Kardigan, Inc.
http://www.kardigan.bioKardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist.
CEO
Tassos Gianakakos
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Biotechnology
Sector Healthcare
Went public June 18, 2026
Method of going public IPO
Full time employees 241
ETFs Holding This Stock
Summary
Total 5
Showing Top 2 of 5
Price Target
Target High $40
Target Low $37
Target Median $38.5
Target Consensus $38.5